Company: MDCXW
Filing Date: 2025-05-05
Form Type: 253G2
Source: 0001062993-25-008440
Chunk: 50

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-05
Form: 253G2
Chunk 50
---
 Conshohocken, Pennsylvania on the 30 day of April, 2025.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               
 Title:              | Dr. Raza Bokhari                               
 Executive Chairman and Chief Executive Officer |

<div align='center'>35

POWER OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Raza Bokhari and James Quinlan his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this amended Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this annual report has been signed below by the following persons in the capacities and on the dates indicated.

| Name                     
 /s/ Raza Bokhari         | Position                     
 Executive Chairman and       | Date           
 April 30, 2025 |
|:-------------------------|:-----------------------------|:---------------|
| Raza Bokhari             | Chief Executive Officer      |                |
|                          | -Principal Executive Officer |                |
| /s/ James Quinlan        | Chief Financial Officer      | April 30, 2025 |
| James Quinlan            | (Principal Financial and     |                |
|                          | Accounting Officer)          |                |
| /s/ Larry Kaiser         | Director                     | April 30, 2025 |
| Dr. Larry Kaiser         |                              |                |
| /s/ Robert J. Ciaruffoli | Director                     | April 30, 2025 |
| Robert J. Ciaruffoli     |                              |